The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells

Shaneabbas Raza, Joyce E. Ohm, Archana Dhasarathy, Jared Schommer, Conor Roche, Kimberly D.P. Hammer, Othman Ghribi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Estrogen is synthesized from cholesterol and high cholesterol levels are suggested to be associated with increased risk of estrogen receptor(ER)-positive breast cancer. The cholesterol metabolite 27-hydroxycholesterol (27-OHC) was recently identified as a selective estrogen receptor modulator (SERM) and may therefore impact breast cancer progression. However, the mechanisms by which 27-OHC may contribute to breast cancer are not all known. We determined the extent to which 27-OHC regulates cell proliferation in MCF7 ER-positive breast cancer cell line involving the tumor suppressor protein p53. We found that treatment of MCF7 cells with 27-OHC resulted reduced p53 transcriptional activity. Conversely, treatment of the ER-negative MDA-MB 231 cells with 27-OHC induced no significant change in p53 activity. Exposure of MCF7 cells to 27-OHC was also associated with increased protein levels of the E3 ubiquitin protein ligase MDM2 and decreased levels of p53. Moreover, 27-OHC also enhanced physical interaction between p53 and MDM2. Furthermore, 27-OHC-induced proliferation was attenuated using either the p53 activator Tenovin-1 or the MDM2 inhibitor Nutlin-3 and Mdm2 siRNA. Taken together, our results indicate that 27-OHC may contribute to ER-positive breast cancer progression by disrupting constitutive p53 signaling in an MDM2-dependent manner.

Original languageEnglish (US)
Pages (from-to)187-195
Number of pages9
JournalMolecular and cellular biochemistry
Volume410
Issue number1-2
DOIs
StatePublished - Sep 8 2015

Fingerprint

Cell proliferation
Metabolites
Estrogen Receptors
Cholesterol
Cells
Cell Proliferation
Breast Neoplasms
MCF-7 Cells
Selective Estrogen Receptor Modulators
Tumor Suppressor Protein p53
Ubiquitin-Protein Ligases
Small Interfering RNA
Estrogens
Hypercholesterolemia
27-hydroxycholesterol
Cell Line
Proteins

Keywords

  • 27-Hydroxycholesterol
  • Breast cancer
  • Cholesterol
  • Estrogen
  • Proliferation

ASJC Scopus subject areas

  • Molecular Biology
  • Clinical Biochemistry
  • Cell Biology

Cite this

The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells. / Raza, Shaneabbas; Ohm, Joyce E.; Dhasarathy, Archana; Schommer, Jared; Roche, Conor; Hammer, Kimberly D.P.; Ghribi, Othman.

In: Molecular and cellular biochemistry, Vol. 410, No. 1-2, 08.09.2015, p. 187-195.

Research output: Contribution to journalArticle

Raza, Shaneabbas ; Ohm, Joyce E. ; Dhasarathy, Archana ; Schommer, Jared ; Roche, Conor ; Hammer, Kimberly D.P. ; Ghribi, Othman. / The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells. In: Molecular and cellular biochemistry. 2015 ; Vol. 410, No. 1-2. pp. 187-195.
@article{b5db00b4284d48ad840179fac26667f4,
title = "The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells",
abstract = "Estrogen is synthesized from cholesterol and high cholesterol levels are suggested to be associated with increased risk of estrogen receptor(ER)-positive breast cancer. The cholesterol metabolite 27-hydroxycholesterol (27-OHC) was recently identified as a selective estrogen receptor modulator (SERM) and may therefore impact breast cancer progression. However, the mechanisms by which 27-OHC may contribute to breast cancer are not all known. We determined the extent to which 27-OHC regulates cell proliferation in MCF7 ER-positive breast cancer cell line involving the tumor suppressor protein p53. We found that treatment of MCF7 cells with 27-OHC resulted reduced p53 transcriptional activity. Conversely, treatment of the ER-negative MDA-MB 231 cells with 27-OHC induced no significant change in p53 activity. Exposure of MCF7 cells to 27-OHC was also associated with increased protein levels of the E3 ubiquitin protein ligase MDM2 and decreased levels of p53. Moreover, 27-OHC also enhanced physical interaction between p53 and MDM2. Furthermore, 27-OHC-induced proliferation was attenuated using either the p53 activator Tenovin-1 or the MDM2 inhibitor Nutlin-3 and Mdm2 siRNA. Taken together, our results indicate that 27-OHC may contribute to ER-positive breast cancer progression by disrupting constitutive p53 signaling in an MDM2-dependent manner.",
keywords = "27-Hydroxycholesterol, Breast cancer, Cholesterol, Estrogen, Proliferation",
author = "Shaneabbas Raza and Ohm, {Joyce E.} and Archana Dhasarathy and Jared Schommer and Conor Roche and Hammer, {Kimberly D.P.} and Othman Ghribi",
year = "2015",
month = "9",
day = "8",
doi = "10.1007/s11010-015-2551-7",
language = "English (US)",
volume = "410",
pages = "187--195",
journal = "Molecular and Cellular Biochemistry",
issn = "0300-8177",
publisher = "Springer Netherlands",
number = "1-2",

}

TY - JOUR

T1 - The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells

AU - Raza, Shaneabbas

AU - Ohm, Joyce E.

AU - Dhasarathy, Archana

AU - Schommer, Jared

AU - Roche, Conor

AU - Hammer, Kimberly D.P.

AU - Ghribi, Othman

PY - 2015/9/8

Y1 - 2015/9/8

N2 - Estrogen is synthesized from cholesterol and high cholesterol levels are suggested to be associated with increased risk of estrogen receptor(ER)-positive breast cancer. The cholesterol metabolite 27-hydroxycholesterol (27-OHC) was recently identified as a selective estrogen receptor modulator (SERM) and may therefore impact breast cancer progression. However, the mechanisms by which 27-OHC may contribute to breast cancer are not all known. We determined the extent to which 27-OHC regulates cell proliferation in MCF7 ER-positive breast cancer cell line involving the tumor suppressor protein p53. We found that treatment of MCF7 cells with 27-OHC resulted reduced p53 transcriptional activity. Conversely, treatment of the ER-negative MDA-MB 231 cells with 27-OHC induced no significant change in p53 activity. Exposure of MCF7 cells to 27-OHC was also associated with increased protein levels of the E3 ubiquitin protein ligase MDM2 and decreased levels of p53. Moreover, 27-OHC also enhanced physical interaction between p53 and MDM2. Furthermore, 27-OHC-induced proliferation was attenuated using either the p53 activator Tenovin-1 or the MDM2 inhibitor Nutlin-3 and Mdm2 siRNA. Taken together, our results indicate that 27-OHC may contribute to ER-positive breast cancer progression by disrupting constitutive p53 signaling in an MDM2-dependent manner.

AB - Estrogen is synthesized from cholesterol and high cholesterol levels are suggested to be associated with increased risk of estrogen receptor(ER)-positive breast cancer. The cholesterol metabolite 27-hydroxycholesterol (27-OHC) was recently identified as a selective estrogen receptor modulator (SERM) and may therefore impact breast cancer progression. However, the mechanisms by which 27-OHC may contribute to breast cancer are not all known. We determined the extent to which 27-OHC regulates cell proliferation in MCF7 ER-positive breast cancer cell line involving the tumor suppressor protein p53. We found that treatment of MCF7 cells with 27-OHC resulted reduced p53 transcriptional activity. Conversely, treatment of the ER-negative MDA-MB 231 cells with 27-OHC induced no significant change in p53 activity. Exposure of MCF7 cells to 27-OHC was also associated with increased protein levels of the E3 ubiquitin protein ligase MDM2 and decreased levels of p53. Moreover, 27-OHC also enhanced physical interaction between p53 and MDM2. Furthermore, 27-OHC-induced proliferation was attenuated using either the p53 activator Tenovin-1 or the MDM2 inhibitor Nutlin-3 and Mdm2 siRNA. Taken together, our results indicate that 27-OHC may contribute to ER-positive breast cancer progression by disrupting constitutive p53 signaling in an MDM2-dependent manner.

KW - 27-Hydroxycholesterol

KW - Breast cancer

KW - Cholesterol

KW - Estrogen

KW - Proliferation

UR - http://www.scopus.com/inward/record.url?scp=84946479943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946479943&partnerID=8YFLogxK

U2 - 10.1007/s11010-015-2551-7

DO - 10.1007/s11010-015-2551-7

M3 - Article

C2 - 26350565

AN - SCOPUS:84946479943

VL - 410

SP - 187

EP - 195

JO - Molecular and Cellular Biochemistry

JF - Molecular and Cellular Biochemistry

SN - 0300-8177

IS - 1-2

ER -